SynthesisJNCI cancer spectrum2021

Radiotherapy and Receptor Tyrosine Kinase Inhibition for Solid Cancers (ROCKIT): A Meta-Analysis of 13 Studies.

Leila T Tchelebi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.